Resting Tremor in Parkinson's: Towards a Targeted Therapy
Dopamine in the caudate nucleus may be a target for a targeted therapy against Parkinsonian tremor, a new study suggests.
Parkinson's, anti-diabetes drug slows down motor symptoms: it's the first time
Lixisenatide injections slow the progression of movement disorders in Parkinson's compared to placebo. Is the first time.
Goodbye implants: sonogenetics controls brain cells from a distance
Through a targeted ultrasound-based activity, sonogenetics promises a future without invasive brain implants, and without Parkinson's.
A brain implant detects and lowers the symptoms of Parkinson's disease
The team tried the technique in 13 people with Parkinson's who had a particular problem with moving too slowly.
The first drug in the world that can block Parkinson's
A new therapy showing the ability to stop Parkinson's disease will begin clinical trials on humans in just 6 months.
The app against Parkinson's disease is born
Precisely today that Parkinson's disease took away Maurice White, founder and ...
